Agenda

Agenda:

Monday 12 December 2005

08.00

Registration

09.00

THEATRE
Chairman's Opening Welcome:
Anthony Warnock Smith, Partner, Morgan Lewis

09.15

Keynote Presentation:
M&A and the IPO Market: The outlook for small cap biotechs
Karl Keegan, Managing Director, Life Sciences Analyst, Canaccord Capital

09.35

Panel Discussion:
The role of VC’s in shaping biotech in 2006 and beyond
Chair:
Stephanie Léouzon, Managing Director, European Healthcare, Credit Suisse First Boston
Panellists:
Joël Besse, Senior Partner, Atlas Venture
Antoine Papiernik, Managing Partner, Sofinnova
Nick Lowcock, Managing Director, Warburg Pincus
Speaker ‚ tbc, Morgan Lewis

10.45

Coffee Break

11.10-12.45

Small-Cap Listed Company Presentations

11.10

ROOM: tbc
Chair: Dimitri Dimitriou, Dyo Delta Biosciences

ROOM: tbc
Chair: Anthony Warnock Smith, Morgan Lewis

11.15

Ardana
Dr Maureen Lindsay
Chief Executive Officer

Biophan Technologies
Michael Weiner
Chief Executive Officer

11.30

Chemokine Therapeuticals
Dr Hassan Salari
President & Chief Executive Officer

Evolutec
Dr Mark Carnegie Brown
Chief Executive Officer

11.45

Orexo
Zsolt Lavotha
President & Chief Executive Officer

tbc

12.00

Phytopharm
Dr Richard Dixey
Chief Executive Officer

tbc

12.15

BioPure Corporation
Zafaris Zafirelis
President & Chief Executive Officer

Avax Technology
Richard Rainey
President

12.30

Alliance Pharma
John Dawson
Chief Executive Officer

Speedel
Dr Alice Huxley
President & Chief Executive Officer

13.00

Lunch

14.00-16.15

Sector Workshops: Venture Funded, Early - Mid Stage Biotech Companies

14.05

ROOM: Theatre
Chair: Emma Palmer, Northbank Communications

ROOM: Forum
Chair: Nessan Bermingham, Atlas Venture

14.10

PowderMed
Dr Clive Dix
Chief Executive Officer

Symphogen
Thomas Feldthus
Chief Financial Officer

14.25

Intercytex
Nick Higgins
Chief Executive Officer

Biobase
Michael Tysiak
Chief Executive Officer

14.40

Apoxis
Dr Jean-Pierre Rosat
Chief Executive Officer

Faust Pharmaceuticals
Pascal Neuville
Chief Scientific Officer

14.55

Avidex
James Noble
Chief Executive Officer

mondoBIOTECH
Dr Lorenzo Leoni
Chief Operating Officer

15.10

Innate Pharma
Stephane Boissel
Vice President, CFO and Corporate Development

ACE BioSciences
Ingelise Saunders
Chief Executive Officer

15.25

Heidelberg Pharma
Dr Jan Schmidt-Brand
Chief Executive Officer

Austrianova Biotechnology
Thomas Fischer
Chief Finance Officer

15.40

Agendia
Dr Bernhard Sixt
Chief Executive Officer

PediaMed – The Pediatrics Company
Dr Cameron Durrant
Chief Executive Officer

15.55

ESBATech
Dr Dominik Escher
Chief Executive Officer

Zealand Pharma
Dr Eva Steiness
Chief Executive Officer

16.10

tbc	Newron Pharmaceuticals Luca Benatti Chief Executive Officer

16.40

Cocktail Reception

To download a pdf version of this agenda click here.